SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-121572
Filing Date
2022-04-27
Accepted
2022-04-27 07:30:53
Documents
10
Period of Report
2022-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d224005ddef14a.htm DEF 14A 439260
2 GRAPHIC g224005g01a20.jpg GRAPHIC 43297
3 GRAPHIC g224005g02x02.jpg GRAPHIC 22516
4 GRAPHIC g224005g17p65.jpg GRAPHIC 35478
5 GRAPHIC g224005g27p31.jpg GRAPHIC 177056
6 GRAPHIC g224005g38t37.jpg GRAPHIC 18190
7 GRAPHIC g224005g75z61.jpg GRAPHIC 38327
8 GRAPHIC g224005g80b87.jpg GRAPHIC 96415
9 GRAPHIC g224005g85b95.jpg GRAPHIC 57897
10 GRAPHIC g224005g99d47.jpg GRAPHIC 41477
  Complete submission text file 0001193125-22-121572.txt   1157521
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 22856375
SIC: 2834 Pharmaceutical Preparations